281 related articles for article (PubMed ID: 8496678)
21. Gene encoding the group B streptococcal protein R4, its presence in clinical reference laboratory isolates & R4 protein pepsin sensitivity.
Smith BL; Flores A; Dechaine J; Krepela J; Bergdall A; Ferrieri P
Indian J Med Res; 2004 May; 119 Suppl():213-20. PubMed ID: 15232198
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.
Seepersaud R; Hanniffy SB; Mayne P; Sizer P; Le Page R; Wells JM
Infect Immun; 2005 Mar; 73(3):1671-83. PubMed ID: 15731068
[TBL] [Abstract][Full Text] [Related]
23. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells.
Stålhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
Mol Microbiol; 1999 Jul; 33(1):208-19. PubMed ID: 10411737
[TBL] [Abstract][Full Text] [Related]
24. Immunological markers of the R4 protein of Streptococcus agalactiae.
Maeland JA; Bevanger L; Lyng RV
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1305-10. PubMed ID: 16275945
[TBL] [Abstract][Full Text] [Related]
25. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.
Johnson DR; Ferrieri P
J Clin Microbiol; 1984 Apr; 19(4):506-10. PubMed ID: 6201506
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of amino acids 1-150 of Streptococcus GapC displayed on the surface of Escherichia coli.
Song B; Yang X; Sun H; Yu L; Ma J; Wu Z; Cui Y
Microb Pathog; 2017 Apr; 105():288-297. PubMed ID: 28179116
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
28. Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates.
Ferrieri P; Baker CJ; Hillier SL; Flores AE
Indian J Med Res; 2004 May; 119 Suppl():191-6. PubMed ID: 15232193
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the alpha antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody.
Bevanger L; Iversen OJ; Naess AI
APMIS; 1992 Jan; 100(1):57-62. PubMed ID: 1536721
[TBL] [Abstract][Full Text] [Related]
30. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.
Gherardi G; Imperi M; Baldassarri L; Pataracchia M; Alfarone G; Recchia S; Orefici G; Dicuonzo G; Creti R
J Clin Microbiol; 2007 Sep; 45(9):2909-16. PubMed ID: 17634303
[TBL] [Abstract][Full Text] [Related]
31. Mosaicism in the alpha-like protein genes of group B streptococci.
Lachenauer CS; Creti R; Michel JL; Madoff LC
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9630-5. PubMed ID: 10944228
[TBL] [Abstract][Full Text] [Related]
32. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
[TBL] [Abstract][Full Text] [Related]
33. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
[TBL] [Abstract][Full Text] [Related]
34. Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.
Kong F; Gowan S; Martin D; James G; Gilbert GL
J Clin Microbiol; 2002 Feb; 40(2):620-6. PubMed ID: 11825981
[TBL] [Abstract][Full Text] [Related]
35. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
36. Mouse-protective effect of rabbit anti-R-protein antibodies against group B streptococci type II carrying R-protein. Lack of effect on type III carrying R-protein.
Lindén V
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):145-51. PubMed ID: 6346797
[TBL] [Abstract][Full Text] [Related]
37. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.
Lindahl G; Stålhammar-Carlemalm M; Areschoug T
Clin Microbiol Rev; 2005 Jan; 18(1):102-27. PubMed ID: 15653821
[TBL] [Abstract][Full Text] [Related]
38. Human IgG antibodies to carbohydrate and protein antigens in mouse protection tests with group B streptococci.
Christensen KK; Christensen P; Duc G; Hitzig WH; Lindén V; Müller B; Seger RA
Pediatr Res; 1984 May; 18(5):478-82. PubMed ID: 6203092
[TBL] [Abstract][Full Text] [Related]
39. Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody.
Valtonen MV; Kasper DL; Levy NJ
Microb Pathog; 1986 Apr; 1(2):191-204. PubMed ID: 3334154
[TBL] [Abstract][Full Text] [Related]
40. The streptococcal Blr and Slr proteins define a family of surface proteins with leucine-rich repeats: camouflaging by other surface structures.
Waldemarsson J; Areschoug T; Lindahl G; Johnsson E
J Bacteriol; 2006 Jan; 188(2):378-88. PubMed ID: 16385027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
